Q&A: Robert Vonderheide on Immunotherapy Advances

Researchers and oncologists have long looked to the body’s own defenses as a possible tool to conquer cancer. To that end, they have developed checkpoint inhibitors, mRNA vaccines, chimeric antigen receptor T-cell therapies, and other treatments. Robert Vonderheide, MD, DPhil, director of the Abramson Cancer Center at the University of Pennsylvania in Philadelphia, talks about where the field has been and what lies ahead.